BMI View: Although we see limited chances for Portugal to improve its competitiveness in order to attract
foreign investment in the near future, rising private consumption and fiscal policy will support
pharmaceutical and healthcare market growth rates over a multi- ..."
BMI View: Portugal's expansionary budget will continue to support rising domestic consumption indices,
which will contribute to modest pharmaceutical market growth rates over a multi-quarter horizon.
However, the government will do little to continue structural reform ..."
BMI View: Portugal's pharmaceutical and healthcare markets are projected to grow, albeit at marginal
rates, over our forecast period. Also, the ongoing normalisation of the operating environment for
drugmakers is expected to continue over the coming years, as illustra ..."
BMI View: Fiscal loosening by the newly-initiated Socialist-led government in Portugal and rising private
consumption will benefit pharmaceutical sales in 2016. According to the latest data on market activity we
have revised upwards our pharmaceutical market forecast, ..."
BMI View: Despite sustained economic growth and buoyant consumption indicators, high public and
private debt levels in Portugal will remain a significant drag on the country's attractiveness to
pharmaceutical companies. While hospital debt levels and payment delays ha ..."
BMI View: Despite the registered recovery in Portugal's economic indicators in recent quarters,
substantial risks will remain to pharmaceutical firms that sell drugs in the country, especially due to delays
in payments by public hospitals and high levels of public and ..."
BMI View: The Portuguese government measures to reduce public spending on medicines will continue to
weigh on the pharmaceutical sector over a multi-quarter horizon, as illustrated by a new cost-containment
agreement between the Ministry of Health and the pharmaceutic ..."
BMI View: Despite Portugal's stronger-than-expected economic expansion in previous quarters,
government austerity measures will continue to weigh on drug spending over the medium term. This is
reflected in recent agreements between the Portuguese government and the ph ..."
BMI View: Faster-than-expected economic growth last quarter has led us to revise our healthcare and
pharmaceutical forecasts slightly upwards. As forecast previously, BMI expects Portugal's healthcare
market to return to growth in 2015, while pharmaceuticals will not ..."
BMI View: While Portugal's economy is expected to register growth in FY14, we expect that IMF-imposed
austerity measures and household deleveraging will continue to be a drag on consumer spending. The
healthcare budget will continue to be slashed in 2014; the authorit ..."